{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:40:33Z","timestamp":1786995633223,"version":"build-2736575974"},"reference-count":239,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018641","name":"Dairy Research Ireland","doi-asserted-by":"publisher","award":["DRI-PA2024-000482"],"award-info":[{"award-number":["DRI-PA2024-000482"]}],"id":[{"id":"10.13039\/501100018641","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V032488\/1"],"award-info":[{"award-number":["MR\/V032488\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","award":["UKDRI-4011"],"award-info":[{"award-number":["UKDRI-4011"]}],"id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","award":["UKDRI-4209"],"award-info":[{"award-number":["UKDRI-4209"]}],"id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","award":["Edin009"],"award-info":[{"award-number":["Edin009"]}],"id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","award":["DRI-TFP-2024-7"],"award-info":[{"award-number":["DRI-TFP-2024-7"]}],"id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.pharmr.2026.100143","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:21:23Z","timestamp":1778628083000},"page":"100143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Friend or foe? Glial\u2013vascular interactions in health and neurodegenerative disease"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5163-8915","authenticated-orcid":false,"given":"Conor","family":"McQuaid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0113-6551","authenticated-orcid":false,"given":"Michael","family":"Sewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5564-985X","authenticated-orcid":false,"given":"Axel","family":"Montagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmr.2026.100143_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.732820","article-title":"The \u201cneuro-glial-vascular\u201d unit: the role of glia in neurovascular unit formation and dysfunction","volume":"9","author":"Kugler","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00401-024-02695-0","article-title":"Endothelial cells and macrophages as allies in the healthy and diseased brain","volume":"147","author":"Denes","year":"2024","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11934","article-title":"Early role of vascular dysregulation on late-onset Alzheimer\u2019s disease based on multifactorial data-driven analysis","volume":"7","author":"Iturria-Medina","year":"2016","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100143_bib5","doi-asserted-by":"crossref","first-page":"C325","DOI":"10.1152\/ajpcell.00333.2018","article-title":"Stroke and the neurovascular unit: glial cells, sex differences, and hypertension","volume":"316","author":"Morrison","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.pharmr.2026.100143_bib6","article-title":"editorial. Editorial: targeting neuron-non-neuronal interactions at the neurovascular unit in stroke and neurodegenerative disease models","volume":"18","author":"Li","year":"2024","journal-title":"Front Cell Neurosci"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100143_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713114","article-title":"A scoping review on biomarkers of endothelial dysfunction in small vessel disease: molecular insights from human studies","volume":"24","author":"Jaime Garcia","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-024-00735-w","article-title":"Neurovascular and immune factors of vulnerability of substantia nigra dopaminergic neurons in non-human primates","volume":"10","author":"Balzano","year":"2024","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.pharmr.2026.100143_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1510897","article-title":"Glial cells improve Parkinson\u2019s disease by modulating neuronal function and regulating neuronal ferroptosis","volume":"12","author":"Li","year":"2025","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100143_bib10","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.4103\/1673-5374.390969","article-title":"Therapeutic advances in neural regeneration for Huntington\u2019s disease","volume":"19","author":"D\u2019Egidio","year":"2023","journal-title":"Neural Regen Res"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100143_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abq1141","article-title":"The link between neuroinflammation and the neurovascular unit in synucleinopathies","volume":"9","author":"Wang","year":"2023","journal-title":"Sci Adv"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100143_bib12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.tins.2023.04.007","article-title":"Disentangling brain vasculature in neurogenesis and neurodegeneration using single-cell transcriptomics","volume":"46","author":"Crouch","year":"2023","journal-title":"Trends Neurosci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100143_bib13","article-title":"Unraveling the transcriptomic landscape of brain vascular cells in dementia: a systematic review","volume":"21","author":"Sewell","year":"2025","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-brain barrier: from physiology to disease and back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib15","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood-brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100143_bib16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1083\/jcb.201412147","article-title":"Brain barriers: crosstalk between complex tight junctions and adherens junctions","volume":"209","author":"Tietz","year":"2015","journal-title":"J Cell Biol"},{"issue":"7693","key":"10.1016\/j.pharmr.2026.100143_bib17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nature25739","article-title":"A molecular atlas of cell types and zonation in the brain vasculature","volume":"554","author":"Vanlandewijck","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib18","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1038\/s41467-020-18249-3","article-title":"Pharmacologically reversible zonation-dependent endothelial cell transcriptomic changes with neurodegenerative disease associations in the aged brain","volume":"11","author":"Zhao","year":"2020","journal-title":"Nat Commun"},{"issue":"7903","key":"10.1016\/j.pharmr.2026.100143_bib19","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/s41586-021-04369-3","article-title":"A human brain vascular atlas reveals diverse mediators of Alzheimer\u2019s risk","volume":"603","author":"Yang","year":"2022","journal-title":"Nature"},{"issue":"8025","key":"10.1016\/j.pharmr.2026.100143_bib20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-024-07493-y","article-title":"Single-cell atlas of the human brain vasculature across development, adulthood and disease","volume":"632","author":"W\u00e4lchli","year":"2024","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100143_bib21","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/s41593-024-01743-y","article-title":"Characteristics of blood-brain barrier heterogeneity between brain regions revealed by profiling vascular and perivascular cells","volume":"27","author":"Pfau","year":"2024","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmr.2026.100143_bib22","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.57520","article-title":"Single-cell transcriptomics reveals functionally specialized vascular endothelium in brain","volume":"11","author":"Jeong","year":"2022","journal-title":"eLife"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100143_bib23","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/s41593-019-0497-x","article-title":"Profiling the mouse brain endothelial transcriptome in health and disease models reveals a core blood-brain barrier dysfunction module","volume":"22","author":"Munji","year":"2019","journal-title":"Nat Neurosci"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100143_bib24","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1523\/JNEUROSCI.0237-23.2023","article-title":"Endothelial cells are heterogeneous in different brain regions and are dramatically altered in Alzheimer\u2019s disease","volume":"43","author":"Bryant","year":"2023","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/brain\/aww271","article-title":"The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor","volume":"140","author":"Capsoni","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.pharmr.2026.100143_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fncel.2018.00165","article-title":"The role of the microtubule cytoskeleton in neurodevelopmental disorders","volume":"12","author":"Lasser","year":"2018","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib27","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1038\/s41467-022-32587-4","article-title":"IFITM3 restricts virus-induced inflammatory cytokine production by limiting Nogo-B mediated TLR responses","volume":"13","author":"Clement","year":"2022","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100143_bib28","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.ajpath.2021.07.003","article-title":"Interplay between brain pericytes and endothelial cells in dementia","volume":"191","author":"Procter","year":"2021","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.celrep.2017.12.016","article-title":"Dynamic remodeling of pericytes in vivo maintains capillary coverage in the adult mouse brain","volume":"22","author":"Berthiaume","year":"2018","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100143_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100052","article-title":"The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: the aberrant pericyte is a central player","volume":"77","author":"Divecha","year":"2025","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100143_bib31","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/0271678X15610340","article-title":"What is a pericyte?","volume":"36","author":"Attwell","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.pharmr.2026.100143_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00282","article-title":"Pericytes and neurovascular function in the healthy and diseased brain","volume":"13","author":"Brown","year":"2019","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100143_bib33","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1084\/jem.20171406","article-title":"Alzheimer\u2019s disease: a matter of blood-brain barrier dysfunction?","volume":"214","author":"Montagne","year":"2017","journal-title":"J Exp Med"},{"issue":"7323","key":"10.1016\/j.pharmr.2026.100143_bib34","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nature09513","article-title":"Pericytes are required for blood-brain barrier integrity during embryogenesis","volume":"468","author":"Daneman","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2026.100143_bib35","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neures.2022.09.006","article-title":"The microglia-blood vessel interactions in the developing brain","volume":"187","author":"Hattori","year":"2023","journal-title":"Neurosci Res"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100143_bib36","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10571-022-01208-5","article-title":"The active role of pericytes during neuroinflammation in the adult brain","volume":"43","author":"Medina-Flores","year":"2023","journal-title":"Cell Mol Neurobiol"},{"issue":"23","key":"10.1016\/j.pharmr.2026.100143_bib37","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1016\/j.neuron.2023.08.030","article-title":"Neuronal activity drives IGF2 expression from pericytes to form long-term memory","volume":"111","author":"Pandey","year":"2023","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100143_bib38","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.jcbfm.9600272","article-title":"CNS microvascular pericytes exhibit multipotential stem cell activity","volume":"26","author":"Dore-Duffy","year":"2006","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100143_bib39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00401-014-1295-x","article-title":"Brain pericytes acquire a microglial phenotype after stroke","volume":"128","author":"\u00d6zen","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100143_bib40","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.240226","article-title":"Pericyte mechanics and mechanobiology","volume":"134","author":"Dessalles","year":"2021","journal-title":"J Cell Sci"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100143_bib41","doi-asserted-by":"crossref","DOI":"10.1242\/dev.200271","article-title":"Biology of vascular mural cells","volume":"150","author":"Siekmann","year":"2023","journal-title":"Development"},{"issue":"7494","key":"10.1016\/j.pharmr.2026.100143_bib42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature13165","article-title":"Capillary pericytes regulate cerebral blood flow in health and disease","volume":"508","author":"Hall","year":"2014","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100143_bib43","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nri.2017.125","article-title":"Microglia and macrophages in brain homeostasis and disease","volume":"18","author":"Li","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100143_bib44","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41593-019-0393-4","article-title":"A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment","volume":"22","author":"Van Hove","year":"2019","journal-title":"Nat Neurosci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100143_bib45","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1073\/pnas.1520398113","article-title":"Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier","volume":"113","author":"Lou","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib46","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1038\/s41467-021-25590-8","article-title":"Capillary-associated microglia regulate vascular structure and function through PANX1-P2RY12 coupling in mice","volume":"12","author":"Bisht","year":"2021","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100143_bib47","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211071","article-title":"Microglia modulate blood flow, neurovascular coupling, and hypoperfusion via purinergic actions","volume":"219","author":"Cs\u00e1sz\u00e1r","year":"2022","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib48","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1038\/s41467-019-13812-z","article-title":"Dual microglia effects on blood brain barrier permeability induced by systemic inflammation","volume":"10","author":"Haruwaka","year":"2019","journal-title":"Nat Commun"},{"issue":"34","key":"10.1016\/j.pharmr.2026.100143_bib49","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.1523\/JNEUROSCI.3006-19.2020","article-title":"A developmental analysis of Juxtavascular microglia dynamics and interactions with the vasculature","volume":"40","author":"Mondo","year":"2020","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib50","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.1038\/s41467-025-60753-x","article-title":"Microglial cyclooxygenase-1 modulates cerebral capillary basal tone in vivo in mice","volume":"16","author":"Mills","year":"2025","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100143_bib51","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nn1715","article-title":"Control of microglial neurotoxicity by the fractalkine receptor","volume":"9","author":"Cardona","year":"2006","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev-neuro-091922-031205","article-title":"Astrocyte endfeet in brain function and pathology: open questions","volume":"46","author":"D\u00edaz-Castro","year":"2023","journal-title":"Annu Rev Neurosci"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100143_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417146","article-title":"Astrocyte involvement in blood-brain barrier function: a critical update highlighting novel, complex, neurovascular interactions","volume":"24","author":"Manu","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100143_bib54","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.3390\/cells11121954","article-title":"Reciprocal interactions between oligodendrocyte precursor cells and the neurovascular unit in health and disease","volume":"11","author":"Pfeiffer","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib55","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12987-023-00425-4","article-title":"Direct association with the vascular basement membrane is a frequent feature of myelinating oligodendrocytes in the neocortex","volume":"20","author":"Palhol","year":"2023","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.pharmr.2026.100143_bib56","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fncel.2015.00340","article-title":"Oligodendrocytes in a nutshell","volume":"9","author":"Michalski","year":"2015","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100143_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114123","article-title":"Oligodendrocyte-derived laminin-\u03b31 regulates the blood-brain barrier and CNS myelination in mice","volume":"43","author":"Kang","year":"2024","journal-title":"Cell Rep"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100143_bib58","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cell.2014.04.052","article-title":"Oligodendrocyte-encoded HIF function couples postnatal myelination and white matter angiogenesis","volume":"158","author":"Yuen","year":"2014","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100143_bib59","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1042\/CS20160618","article-title":"Endothelial cell-oligodendrocyte interactions in small vessel disease and aging","volume":"131","author":"Rajani","year":"2017","journal-title":"Clin Sci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100143_bib60","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1002\/alz.13678","article-title":"Astroglial activation: current concepts and future directions","volume":"20","author":"Edison","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.pharmr.2026.100143_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2018.00193","article-title":"Emerging roles of astrocytes in neuro-vascular unit and the tripartite synapse with emphasis on reactive gliosis in the context of Alzheimer\u2019s disease","volume":"12","author":"Liu","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.pharmr.2026.100143_bib62","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","article-title":"The blood-brain barrier in Alzheimer\u2019s disease","volume":"107","author":"Zenaro","year":"2017","journal-title":"Neurobiol Dis"},{"issue":"7806","key":"10.1016\/j.pharmr.2026.100143_bib63","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms4413","article-title":"Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity","volume":"5","author":"Yao","year":"2014","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100143_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114002","article-title":"Endocytic activation and exosomal secretion of matriptase stimulate the second wave of EGF signaling to promote skin and breast cancer invasion","volume":"43","author":"Ye","year":"2024","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100143_bib66","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1038\/s41380-022-01511-z","article-title":"The blood-brain barrier in aging and neurodegeneration","volume":"27","author":"Knox","year":"2022","journal-title":"Mol Psychiatry"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100143_bib67","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nn.4288","article-title":"Pericytes of the neurovascular unit: key functions and signaling pathways","volume":"19","author":"Sweeney","year":"2016","journal-title":"Nat Neurosci"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100143_bib68","doi-asserted-by":"crossref","first-page":"6592","DOI":"10.3390\/ijms25126592","article-title":"Signaling role of pericytes in vascular health and tissue homeostasis","volume":"25","author":"Fazio","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100143_bib69","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1242\/dev.096107","article-title":"Notch3 establishes brain vascular integrity by regulating pericyte number","volume":"141","author":"Wang","year":"2014","journal-title":"Development"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100143_bib70","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125940","article-title":"Deficiency of Notch signaling in pericytes results in arteriovenous malformations","volume":"5","author":"Nadeem","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.pharmr.2026.100143_bib71","article-title":"The pericyte: a critical cell in the pathogenesis of CADASIL","volume":"2","author":"Ruchoux","year":"2021","journal-title":"Cereb Circ Cogn Behav"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100143_bib72","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00401-016-1551-3","article-title":"Angiopoietin-2-induced blood-brain barrier compromise and increased stroke size are rescued by VE-PTP-dependent restoration of Tie2 signaling","volume":"131","author":"Gurnik","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib73","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1083\/jcb.201802076","article-title":"N-cadherin signaling via Trio assembles adherens junctions to restrict endothelial permeability","volume":"218","author":"Kruse","year":"2019","journal-title":"J Cell Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib74","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12974-016-0503-0","article-title":"TGF-beta1 regulates human brain pericyte inflammatory processes involved in neurovasculature function","volume":"13","author":"Rustenhoven","year":"2016","journal-title":"J Neuroinflammation"},{"issue":"26","key":"10.1016\/j.pharmr.2026.100143_bib75","doi-asserted-by":"crossref","first-page":"15859","DOI":"10.1073\/pnas.2136855100","article-title":"Transforming growth factor beta1 induction of vascular endothelial growth factor receptor 1: mechanism of pericyte-induced vascular survival in vivo","volume":"100","author":"Shih","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7501","key":"10.1016\/j.pharmr.2026.100143_bib76","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature13324","article-title":"MSFD2A is critical for the formation and function of the blood brain barrier","volume":"509","author":"Ben-Zvi","year":"2014","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100143_bib77","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.neuron.2022.02.017","article-title":"Pericyte-to-endothelial cell signaling via vitronectin-integrin regulates blood-CNS barrier","volume":"110","author":"Ayloo","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.pharmr.2026.100143_bib78","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.neuint.2017.04.014","article-title":"Poly(ADP-ribose) polymerase-1 regulates microglia mediated decrease of endothelial tight junction integrity","volume":"108","author":"Mehrabadi","year":"2017","journal-title":"Neurochem Int"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100143_bib79","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/glia.24371","article-title":"Microglia directly associate with pericytes in the central nervous system","volume":"71","author":"Morris","year":"2023","journal-title":"Glia"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100143_bib80","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.neuron.2024.07.015","article-title":"Microglia are not necessary for maintenance of blood-brain barrier properties in health, but PLX5622 alters brain endothelial cholesterol metabolism","volume":"112","author":"Profaci","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.pharmr.2026.100143_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134594","article-title":"Oligodendrocytes upregulate blood-brain barrier function through mechanisms other than the PDGF-BB\/PDGFR\u03b1 pathway in the barrier-tightening effect of oligodendrocyte progenitor cells","volume":"715","author":"Kimura","year":"2020","journal-title":"Neurosci Lett"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100143_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103174","article-title":"Oligodendrocyte precursor cells support blood-brain barrier integrity via TGF-\u03b2 signaling","volume":"9","author":"Seo","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100143_bib83","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","article-title":"Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation","volume":"14","author":"B\u00e9langer","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmr.2026.100143_bib84","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fnins.2014.00103","article-title":"The contribution of astrocytes to the regulation of cerebral blood flow","volume":"8","author":"Howarth","year":"2014","journal-title":"Front Neurosci"},{"issue":"7321","key":"10.1016\/j.pharmr.2026.100143_bib85","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature09613","article-title":"Glial and neuronal control of brain blood flow","volume":"468","author":"Attwell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2026.100143_bib86","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neuroscience.2015.03.064","article-title":"Beyond neurovascular coupling, role of astrocytes in the regulation of vascular tone","volume":"323","author":"Filosa","year":"2016","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100143_bib87","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/nn.4428","article-title":"Astrocytes mediate neurovascular signaling to capillary pericytes but not to arterioles","volume":"19","author":"Mishra","year":"2016","journal-title":"Nat Neurosci"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100143_bib88","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41577-022-00694-4","article-title":"Immunomodulation by endothelial cells \u2014 partnering up with the immune system?","volume":"22","author":"Amersfoort","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100143_bib89","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/s41591-019-0440-4","article-title":"Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1","volume":"25","author":"Yousef","year":"2019","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100143_bib90","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","article-title":"A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria","volume":"23","author":"H\u00f6glinger","year":"2024","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib91","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1742-2094-8-139","article-title":"Brain microvascular pericytes are immunoactive in culture: cytokine, chemokine, nitric oxide, and LRP-1 expression in response to lipopolysaccharide","volume":"8","author":"Kovac","year":"2011","journal-title":"J Neuroinflammation"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100143_bib92","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/glia.22686","article-title":"Systemic inflammation regulates microglial responses to tissue damage in vivo","volume":"62","author":"Gyoneva","year":"2014","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib93","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuron.2018.08.030","article-title":"PDGFR\u03b2 cells rapidly relay inflammatory signal from the circulatory system to neurons via chemokine CCL2","volume":"100","author":"Duan","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.pharmr.2026.100143_bib94","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainres.2018.04.023","article-title":"TNF-\u03b1-sensitive brain pericytes activate microglia by releasing IL-6 through cooperation between I\u03baB-NF\u03baB and JAK-STAT3 pathways","volume":"1692","author":"Matsumoto","year":"2018","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100143_bib95","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tips.2016.12.001","article-title":"Brain pericytes as mediators of neuroinflammation","volume":"38","author":"Rustenhoven","year":"2017","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib96","first-page":"1","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"6381","key":"10.1016\/j.pharmr.2026.100143_bib97","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1126\/science.aal3589","article-title":"Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development","volume":"359","author":"Vainchtein","year":"2018","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100143_bib98","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1523\/JNEUROSCI.1201-21.2021","article-title":"Embryonic pericytes promote microglial homeostasis and their effects on neural progenitors in the developing cerebral cortex","volume":"42","author":"Hattori","year":"2022","journal-title":"J Neurosci"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100143_bib99","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.3390\/cells11172728","article-title":"Role of microglia and astrocytes in Alzheimer\u2019s disease: from neuroinflammation to Ca2+ homeostasis dysregulation","volume":"11","author":"Di Benedetto","year":"2022","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100143_bib100","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction","volume":"25","author":"Nation","year":"2019","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib101","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1038\/s41467-024-46630-z","article-title":"A single nuclear transcriptomic characterisation of mechanisms responsible for impaired angiogenesis and blood-brain barrier function in Alzheimer\u2019s disease","volume":"15","author":"Tsartsalis","year":"2024","journal-title":"Nat Commun"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100143_bib102","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1016\/j.neuron.2022.10.015","article-title":"Microglial efferocytosis: diving into the Alzheimer\u2019s disease gene pool","volume":"110","author":"Romero-Molina","year":"2022","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib103","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40035-024-00430-z","article-title":"Blood-brain barrier alterations and their impact on Parkinson\u2019s disease pathogenesis and therapy","volume":"13","author":"Lau","year":"2024","journal-title":"Transl Neurodegener"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100143_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110961","article-title":"Absence of microglia promotes diverse pathologies and early lethality in Alzheimer\u2019s disease mice","volume":"39","author":"Kiani Shabestari","year":"2022","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/glia.24461","article-title":"Endothelial senescence alleviates cognitive impairment in a mouse model of Alzheimer\u2019s disease","volume":"72","author":"Horibe","year":"2024","journal-title":"Glia"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100143_bib106","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.neuron.2025.01.006","article-title":"Loss of endothelial CD2AP causes sex-dependent cerebrovascular dysfunction","volume":"113","author":"Vandal","year":"2025","journal-title":"Neuron"},{"issue":"8049","key":"10.1016\/j.pharmr.2026.100143_bib107","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41586-024-08350-8","article-title":"Brain-wide cell-type-specific transcriptomic signatures of healthy ageing in mice","volume":"638","author":"Jin","year":"2025","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100143_bib108","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41593-023-01334-3","article-title":"Single-nucleus multiregion transcriptomic analysis of brain vasculature in Alzheimer\u2019s disease","volume":"26","author":"Sun","year":"2023","journal-title":"Nat Neurosci"},{"issue":"6450","key":"10.1016\/j.pharmr.2026.100143_bib109","doi-asserted-by":"crossref","DOI":"10.1126\/science.aav9518","article-title":"Amyloid \u03b2 oligomers constrict human capillaries in Alzheimer\u2019s disease via signaling to pericytes","volume":"365","author":"Nortley","year":"2019","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s41232-022-00193-y","article-title":"Central nervous system regeneration: the roles of glial cells in the potential molecular mechanism underlying remyelination","volume":"42","author":"Quan","year":"2022","journal-title":"Inflamm Regen"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib111","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13024-018-0286-0","article-title":"Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-\u03b242 by LRP1-dependent apolipoprotein E isoform-specific mechanism","volume":"13","author":"Ma","year":"2018","journal-title":"Mol Neurodegeneration"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100143_bib112","first-page":"2752","article-title":"The identification of a distinct astrocyte subtype that diminishes in Alzheimer's disease","volume":"15","author":"Wei","year":"2024","journal-title":"Aging Dis"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib113","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1038\/s41467-024-48926-6","article-title":"Gliovascular transcriptional perturbations in Alzheimer\u2019s disease reveal molecular mechanisms of blood brain barrier dysfunction","volume":"15","author":"\u0130\u015f","year":"2024","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100143_bib114","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41593-023-01257-z","article-title":"Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer\u2019s disease","volume":"26","author":"De Schepper","year":"2023","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100143_bib115","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/jnc.15954","article-title":"Amyloid-\u03b2 exposed astrocytes induce iron transport from endothelial cells at the blood-brain barrier by altering the ratio of apo- and holo-transferrin","volume":"167","author":"Baringer","year":"2023","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmr.2026.100143_bib116","article-title":"APOE-\u03b54-induced fibronectin at the blood-brain barrier is a conserved pathological mediator of disrupted astrocyte-endothelia interaction in Alzheimer\u2019s disease","author":"Bhattarai","year":"2025","journal-title":"bioRxiv"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100143_bib117","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1093\/brain\/awab478","article-title":"APOE4 derived from astrocytes leads to blood-brain barrier impairment","volume":"145","author":"Jackson","year":"2022","journal-title":"Brain J Neurol"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100143_bib118","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.4103\/1673-5374.371362","article-title":"Wrapping up the role of pericytes in Parkinson\u2019s disease","volume":"18","author":"Stevenson","year":"2023","journal-title":"Neural Regen Res"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100143_bib119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0277658","article-title":"Human pericytes degrade diverse \u03b1-synuclein aggregates","volume":"17","author":"Dieriks","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib120","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-20261-0","article-title":"Pericytes take up and degrade \u03b1-synuclein but succumb to apoptosis under cellular stress","volume":"12","author":"Stevenson","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2026.100143_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105028","article-title":"Microglia and astrocyte dysfunction in Parkinson\u2019s disease","volume":"144","author":"Kam","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmr.2026.100143_bib122","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mvr.2019.03.005","article-title":"Monomeric \u03b1-synuclein induces blood-brain barrier dysfunction through activated brain pericytes releasing inflammatory mediators in vitro","volume":"124","author":"Dohgu","year":"2019","journal-title":"Microvasc Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib123","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1038\/s41467-023-39038-8","article-title":"The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson\u2019s disease","volume":"14","author":"de Rus Jacquet","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib124","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12974-021-02218-8","article-title":"High-fat diet-induced diabetes leads to vascular alterations, pericyte reduction, and perivascular depletion of microglia in a 6-OHDA toxin model of Parkinson disease","volume":"18","author":"Elabi","year":"2021","journal-title":"J Neuroinflammation"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100143_bib125","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41588-020-0610-9","article-title":"Genetic identification of cell types underlying brain complex traits yields insights into the etiology of Parkinson\u2019s disease","volume":"52","author":"Bryois","year":"2020","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100143_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115266","article-title":"Oligodendrocytes drive neuroinflammation and neurodegeneration in Parkinson\u2019s disease via the prosaposin-GPR37-IL-6 axis","volume":"44","author":"Ma","year":"2025","journal-title":"Cell Rep"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100143_bib127","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s12276-021-00649-0","article-title":"Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms","volume":"53","author":"Kang","year":"2021","journal-title":"Exp Mol Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib128","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1038\/s41467-021-26066-5","article-title":"Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption","volume":"12","author":"Pediaditakis","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2026.100143_bib129","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.018","article-title":"Alpha synuclein is transported into and out of the brain by the blood-brain barrier","volume":"62","author":"Sui","year":"2014","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41531-026-01276-0","article-title":"Altered cerebrovascular haemodynamics in Parkinson\u2019s disease: insights from 4D flow MRI","volume":"12","author":"Deane","year":"2026","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.pharmr.2026.100143_bib131","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419838354","article-title":"Cerebral blood flow and cerebrovascular reactivity correlate with severity of motor symptoms in Parkinson\u2019s disease","volume":"12","author":"Pelizzari","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100143_bib132","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1877718X241308168","article-title":"From blood vessels to brain cells: connecting the circulatory system and Parkinson\u2019s disease","volume":"15","author":"Olaoye","year":"2025","journal-title":"J Parkinsons Dis"},{"issue":"9557","key":"10.1016\/j.pharmr.2026.100143_bib133","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington\u2019s disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.pharmr.2026.100143_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104963","article-title":"The contribution of glial cells to Huntington\u2019s disease pathogenesis","volume":"143","author":"Wilton","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmr.2026.100143_bib135","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.663898","article-title":"Impaired cerebrovascular reactivity in Huntington\u2019s disease","volume":"12","author":"Chan","year":"2021","journal-title":"Front Physiol"},{"issue":"7903","key":"10.1016\/j.pharmr.2026.100143_bib136","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/s41586-022-04521-7","article-title":"Single-cell dissection of the human brain vasculature","volume":"603","author":"Garcia","year":"2022","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100143_bib137","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ana.24428","article-title":"Aberrant astrocytes impair vascular reactivity in Huntington disease","volume":"78","author":"Hsiao","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmr.2026.100143_bib138","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.expneurol.2018.03.015","article-title":"Brain pericyte activation occurs early in Huntington\u2019s disease","volume":"305","author":"Padel","year":"2018","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib139","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12987-022-00347-7","article-title":"Brain microvascular endothelial cell dysfunction in an isogenic juvenile iPSC model of Huntington\u2019s disease","volume":"19","author":"Linville","year":"2022","journal-title":"Fluids Barriers CNS"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100143_bib140","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/hmg\/ddac303","article-title":"An altered extracellular matrix-integrin interface contributes to Huntington\u2019s disease-associated CNS dysfunction in glial and vascular cells","volume":"32","author":"Hernandez","year":"2023","journal-title":"Hum Mol Genet"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100143_bib141","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.molmed.2023.07.010","article-title":"Oligodendrocyte pathology in Huntington\u2019s disease: from mechanisms to therapeutics","volume":"29","author":"Ferrari Bardile","year":"2023","journal-title":"Trends Mol Med"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib142","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s40478-024-01871-3","article-title":"Mapping the glial transcriptome in Huntington\u2019s disease using snRNAseq: selective disruption of glial signatures across brain regions","volume":"12","author":"B\u00f8strand","year":"2024","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100143_bib143","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.3390\/ijms26041432","article-title":"Endothelial dysfunction in Huntington\u2019s disease: pathophysiology and therapeutic implications","volume":"26","author":"Hu","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100143_bib144","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1474-4422(11)70105-3","article-title":"Vascular aspects of multiple sclerosis","volume":"10","author":"D\u2019haeseleer","year":"2011","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100143_bib145","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1097\/MS9.0000000000001177","article-title":"Vascular multiple sclerosis: addressing the pathogenesis, genetics, pro-angiogenic factors, and vascular abnormalities, along with the role of vascular intervention","volume":"85","author":"Prajjwal","year":"2023","journal-title":"Ann Med Surg"},{"issue":"19","key":"10.1016\/j.pharmr.2026.100143_bib146","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1016\/j.neuron.2024.05.025","article-title":"Neurodegeneration and demyelination in multiple sclerosis","volume":"112","author":"Garton","year":"2024","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100143_bib147","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/glia.24655","article-title":"Multiple sclerosis: glial cell diversity in time and space","volume":"73","author":"Kooistra","year":"2025","journal-title":"Glia"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100143_bib148","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.celrep.2017.08.007","article-title":"Pericytes stimulate oligodendrocyte progenitor cell differentiation during CNS remyelination","volume":"20","author":"De La Fuente","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.pharmr.2026.100143_bib149","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.918041","article-title":"Single-nucleus RNA-seq of normal-appearing brain regions in relapsing-remitting vs. secondary progressive multiple sclerosis: implications for the efficacy of fingolimod","volume":"16","author":"Kihara","year":"2022","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100143_bib150","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41593-019-0369-4","article-title":"Aberrant oligodendroglial-vascular interactions disrupt the blood-brain barrier, triggering CNS inflammation","volume":"22","author":"Niu","year":"2019","journal-title":"Nat Neurosci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib151","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/s41467-024-46068-3","article-title":"Profiling of microglia nodules in multiple sclerosis reveals propensity for lesion formation","volume":"15","author":"van den Bosch","year":"2024","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100143_bib152","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.cell.2024.02.030","article-title":"Cellular architecture of evolving neuroinflammatory lesions and multiple sclerosis pathology","volume":"187","author":"Kukanja","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib153","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12974-024-03069-9","article-title":"Inflammation-induced TRPV4 channels exacerbate blood-brain barrier dysfunction in multiple sclerosis","volume":"21","author":"Hansen","year":"2024","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.pharmr.2026.100143_bib154","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.761225","article-title":"A systematic review of tissue and single cell transcriptome\/proteome studies of the brain in multiple sclerosis","volume":"13","author":"Elkjaer","year":"2022","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100143_bib155","doi-asserted-by":"crossref","DOI":"10.1242\/dev.201047","article-title":"Microglia refine developing retinal astrocytic and vascular networks through the complement C3\/C3aR axis","volume":"150","author":"Gnanaguru","year":"2023","journal-title":"Development"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100143_bib156","article-title":"Plasma lipids as biomarkers for Alzheimer's disease: a systematic review","volume":"12","author":"Agarwal","year":"2020","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100143_bib157","article-title":"Alzheimer\u2019s disease and stroke: a tangled neurological conundrum","volume":"14","author":"Gupta","year":"2022","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100143_bib158","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/13872877251333450","article-title":"A\u03b242\/40 and p-tau 181 as disease biomarkers in atypical Alzheimer's disease","volume":"105","author":"Singh-Reilly","year":"2025","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pharmr.2026.100143_bib159","article-title":"Endothelial tPA-dependent recruitment of microglia to vessels protects the blood-brain barrier after stroke in mice","author":"Etuz\u00e9","year":"2025","journal-title":"bioRxiv"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100143_bib160","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/01.STR.0000206281.77178.ac","article-title":"Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro","volume":"37","author":"Yenari","year":"2006","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100143_bib161","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00401-014-1372-1","article-title":"Perivascular microglia promote blood vessel disintegration in the ischemic penumbra","volume":"129","author":"Jolivel","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100143_bib162","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41419-019-1716-9","article-title":"Microglia-derived TNF-\u03b1 mediates endothelial necroptosis aggravating blood brain\u2013barrier disruption after ischemic stroke","volume":"10","author":"Chen","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.pharmr.2026.100143_bib163","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuroscience.2023.08.010","article-title":"Simultaneous pericytes and M2 microglia transplantation improve cognitive function in mice model of mPFC ischemia","volume":"529","author":"Hossein Geranmayeh","year":"2023","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib164","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12974-016-0523-9","article-title":"Brain pericytes serve as microglia-generating multipotent vascular stem cells following ischemic stroke","volume":"13","author":"Sakuma","year":"2016","journal-title":"J Neuroinflammation"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100143_bib165","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00018-022-04322-1","article-title":"SMAlow\/undetectable pericytes differentiate into microglia- and macrophage-like cells in ischemic brain","volume":"79","author":"Nirwane","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100143_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114193","article-title":"Astrocytic Slc4a4 regulates blood-brain barrier integrity in healthy and stroke brains via a CCL2-CCR2 pathway and NO dysregulation","volume":"43","author":"Ye","year":"2024","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100143_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109048","article-title":"Reactive astrocytes facilitate vascular repair and remodeling after stroke","volume":"35","author":"Williamson","year":"2021","journal-title":"Cell Rep"},{"issue":"7","key":"10.1016\/j.pharmr.2026.100143_bib168","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S1474-4422(19)30079-1","article-title":"Small vessel disease: mechanisms and clinical implications","volume":"18","author":"Wardlaw","year":"2019","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100143_bib169","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00401-022-02441-4","article-title":"Loss of the heterogeneous expression of flippase ATP11B leads to cerebral small vessel disease in a normotensive rat model","volume":"144","author":"Quick","year":"2022","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib170","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/jnnp-2020-323894","article-title":"In vivo neuroinflammation and cerebral small vessel disease in mild cognitive impairment and Alzheimer\u2019s disease","volume":"92","author":"Low","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100143_bib171","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1523\/JNEUROSCI.1333-22.2023","article-title":"Targeting astrocyte signaling alleviates cerebrovascular and synaptic function deficits in a diet-based mouse model of small cerebral vessel disease","volume":"43","author":"Sompol","year":"2023","journal-title":"J Neurosci"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100143_bib172","doi-asserted-by":"crossref","DOI":"10.1172\/JCI172841","article-title":"Pathophysiology of cerebral small vessel disease: a journey through recent discoveries","volume":"134","author":"Dupr\u00e9","year":"2024","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100143_bib173","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41583-024-00892-0","article-title":"Endothelial cells as key players in cerebral small vessel disease","volume":"26","author":"Kremer","year":"2025","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100143_bib174","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neuron.2025.10.001","article-title":"The brain neurovascular epigenome and its association with dementia","volume":"114","author":"Ziegler","year":"2026","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib175","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s40001-026-03840-z","article-title":"Neuroinflammation and blood-brain barrier dysfunction in cerebral small vessel disease: mechanisms, biomarkers, and therapeutic implications","volume":"31","author":"Luo","year":"2026","journal-title":"Eur J Med Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib176","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s12035-026-05778-z","article-title":"The molecular neurobiology of NG2-expressing glial cells in cerebral small vessel disease pathogenesis","volume":"63","author":"Hein","year":"2026","journal-title":"Mol Neurobiol"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100143_bib177","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","article-title":"Disease-associated microglia: a universal immune sensor of neurodegeneration","volume":"173","author":"Deczkowska","year":"2018","journal-title":"Cell"},{"issue":"8030","key":"10.1016\/j.pharmr.2026.100143_bib178","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s41586-024-07871-6","article-title":"Cellular communities reveal trajectories of brain ageing and Alzheimer\u2019s disease","volume":"633","author":"Green","year":"2024","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100143_bib179","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41592-019-0667-5","article-title":"NicheNet: modeling intercellular communication by linking ligands to target genes","volume":"17","author":"Browaeys","year":"2020","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib180","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","article-title":"CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics","volume":"20","author":"Jin","year":"2025","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib181","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1038\/s41467-022-30755-0","article-title":"Comparison of methods and resources for cell-cell communication inference from single-cell RNA-Seq data","volume":"13","author":"Dimitrov","year":"2022","journal-title":"Nat Commun"},{"issue":"6636","key":"10.1016\/j.pharmr.2026.100143_bib182","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1126\/science.abq4822","article-title":"Droplet-based forward genetic screening of astrocyte\u2013microglia cross-talk","volume":"379","author":"Wheeler","year":"2023","journal-title":"Science"},{"issue":"6540","key":"10.1016\/j.pharmr.2026.100143_bib183","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf1230","article-title":"Barcoded viral tracing of single-cell interactions in central nervous system inflammation","volume":"372","author":"Clark","year":"2021","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100143_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114216","article-title":"Microglia-astrocyte crosstalk in the amyloid plaque niche of an Alzheimer\u2019s disease mouse model, as revealed by spatial transcriptomics","volume":"43","author":"Mallach","year":"2024","journal-title":"Cell Rep"},{"issue":"17","key":"10.1016\/j.pharmr.2026.100143_bib185","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1038\/s44319-025-00529-y","article-title":"Astrocyte diversity and subtypes: aligning transcriptomics with multimodal perspectives","volume":"26","author":"Hennes","year":"2025","journal-title":"EMBO Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib186","doi-asserted-by":"crossref","first-page":"9750","DOI":"10.1038\/s41467-025-65487-4","article-title":"Molecular profiling of brain endothelial cell to astrocyte endfoot communication in mouse and human","volume":"16","author":"Hill","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2026.100143_bib187","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.573775","article-title":"Design and validation of a human brain endothelial microvessel-on-a-chip open microfluidic model enabling advanced optical imaging","volume":"8","author":"Salman","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"issue":"42","key":"10.1016\/j.pharmr.2026.100143_bib188","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2511596122","article-title":"Engineered 3D immuno-glial-neurovascular human miBrain model","volume":"122","author":"Stanton","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmr.2026.100143_bib189","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neuroscience.2021.08.003","article-title":"Magnetic resonance imaging of blood-brain barrier permeability in dementia","volume":"474","author":"Chagnot","year":"2021","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12987-025-00621-4","article-title":"Endothelial and neuronal engagement by AAV-BR1 gene therapy alleviates neurological symptoms and lipid deposition in a mouse model of Niemann-Pick type C2","volume":"22","author":"Rasmussen","year":"2025","journal-title":"Fluids Barriers CNS"},{"issue":"14","key":"10.1016\/j.pharmr.2026.100143_bib191","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.neuron.2022.05.003","article-title":"Engineered AAVs for non-invasive gene delivery to rodent and non-human primate nervous systems","volume":"110","author":"Chen","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.pharmr.2026.100143_bib192","doi-asserted-by":"crossref","DOI":"10.3389\/abp.2026.15740","article-title":"Advances in endothelial cell targeting by AAV vectors","volume":"73","author":"Cichon","year":"2026","journal-title":"Acta Biochim Pol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib193","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck CH van","year":"2023","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.pharmr.2026.100143_bib194","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.3390\/ijms24054367","article-title":"Aducanumab\u2014hope or disappointment for Alzheimer\u2019s disease","volume":"24","author":"Wojtunik-Kulesza","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib195","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/healthcare11010032","article-title":"Donanemab for Alzheimer\u2019s disease: a systematic review of clinical trials","volume":"11","author":"Rashad","year":"2022","journal-title":"Healthcare"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100143_bib196","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.12969","article-title":"CNS inflammation after natalizumab therapy for multiple sclerosis: a retrospective histopathological and CSF cohort study","volume":"31","author":"H\u00e4usler","year":"2021","journal-title":"Brain Pathol"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100143_bib197","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3174\/ajnr.A1987","article-title":"Bevacizumab (Avastin)","volume":"31","author":"Mukherji","year":"2010","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib198","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/0976-500X.77118","article-title":"Fingolimod (FTY720): first approved oral therapy for multiple sclerosis","volume":"2","author":"Sharma","year":"2011","journal-title":"J Pharmacol Pharmacother"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100143_bib199","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmr.2026.100143_bib200","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1139359","article-title":"Mesenchymal stem cell therapy for neurological disorders: the light or the dark side of the force?","volume":"11","author":"Isakovi\u0107","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib202","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.1038\/s41598-019-44368-z","article-title":"Efficacy of recombinant human BMP2 and PDGF-BB in orofacial bone regeneration: a systematic review and meta-analysis","volume":"9","author":"Li","year":"2019","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100143_bib203","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1161\/STROKEAHA.124.047207","article-title":"First-in-human Phase I clinical trial of the adenosine A1R\/A3R agonist AST-004 in healthy subjects","volume":"55","author":"Manna","year":"2024","journal-title":"Stroke"},{"key":"10.1016\/j.pharmr.2026.100143_bib204","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114884","article-title":"CSF1R inhibitors are emerging immunotherapeutic drugs for cancer treatment","volume":"245","author":"Wen","year":"2023","journal-title":"Eur J Med Chem"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100143_bib205","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.1158\/1078-0432.CCR-20-0855","article-title":"Immunomodulatory activity of a colony-stimulating Factor-1 receptor inhibitor in patients with advanced refractory breast or prostate cancer: a phase I study","volume":"26","author":"Autio","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib206","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41467-024-45818-7","article-title":"Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I\/II clinical trial","volume":"15","author":"Carpentier","year":"2024","journal-title":"Nat Commun"},{"issue":"20","key":"10.1016\/j.pharmr.2026.100143_bib207","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1056\/NEJMoa2304430","article-title":"Two Phase 3 trials of gantenerumab in early Alzheimer\u2019s disease","volume":"389","author":"Bateman","year":"2023","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.pharmr.2026.100143_bib208","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1080\/14712598.2018.1543397","article-title":"Grasping at straws: the failure of solanezumab to modify mild Alzheimer\u2019s disease","volume":"18","author":"Doggrell","year":"2018","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib209","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13195-024-01599-1","article-title":"Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer\u2019s disease","volume":"16","author":"Long","year":"2024","journal-title":"Alz Res Therapy"},{"issue":"9","key":"10.1016\/j.pharmr.2026.100143_bib210","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.it.2020.07.001","article-title":"To kill a microglia: a case for CSF1R inhibitors","volume":"41","author":"Green","year":"2020","journal-title":"Trends Immunol"},{"issue":"6","key":"10.1016\/j.pharmr.2026.100143_bib211","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3390\/cells14060414","article-title":"Pharmacological inhibition of microglial proliferation supports blood-brain barrier integrity in experimental autoimmune encephalomyelitis","volume":"14","author":"Borjini","year":"2025","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100143_bib212","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1158\/1078-0432.CCR-14-1845","article-title":"An open-label, multicenter, Phase I\/II study of JNJ-40346527, a CSF-1R inhibitor, in patients with relapsed or refractory Hodgkin lymphoma","volume":"21","author":"von Tresckow","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100143_bib213","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104159","article-title":"Premise and peril of Wnt signaling activation through GSK-3\u03b2 inhibition","volume":"25","author":"Law","year":"2022","journal-title":"iScience"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100143_bib214","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2417224122","article-title":"Inhibiting 15-PGDH blocks blood-brain barrier deterioration and protects mice from Alzheimer\u2019s disease and traumatic brain injury","volume":"122","author":"Koh","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib215","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.1038\/ncomms9997","article-title":"EPPS rescues hippocampus-dependent cognitive deficits in APP\/PS1 mice by disaggregation of amyloid-\u03b2 oligomers and plaques","volume":"6","author":"Kim","year":"2015","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100143_bib216","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/1567205014666170117141330","article-title":"Poor safety and tolerability hamper reaching a potentially therapeutic dose in the use of thalidomide for Alzheimer\u2019s disease: results from a double-blind, placebo-controlled trial","volume":"14","author":"Decourt","year":"2017","journal-title":"Curr Alzheimer Res"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100143_bib217","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/npp.2011.191","article-title":"7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer\u2019s disease","volume":"37","author":"Devi","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib218","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13024-016-0119-y","article-title":"Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer\u2019s disease","volume":"11","author":"Kazim","year":"2016","journal-title":"Mol Neurodegeneration"},{"issue":"11","key":"10.1016\/j.pharmr.2026.100143_bib219","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.3390\/molecules29112614","article-title":"Zeolite and neurodegenerative diseases","volume":"29","author":"Panaiotov","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.pharmr.2026.100143_bib220","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.917527","article-title":"A brief overview on BDNF-Trk pathway in the nervous system: a potential biomarker or possible target in treatment of multiple sclerosis?","volume":"13","author":"Schir\u00f2","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.pharmr.2026.100143_bib221","author":"Rashi"},{"issue":"8","key":"10.1016\/j.pharmr.2026.100143_bib222","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3390\/pharmaceutics13081183","article-title":"Solid lipid nanoparticles (SLNs): an advanced drug delivery system targeting brain through BBB","volume":"13","author":"Satapathy","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharmr.2026.100143_bib223","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112117","article-title":"Nanotechnology-based drug delivery for central nervous system disorders","volume":"143","author":"Nguyen","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pharmr.2026.100143_bib224","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.788128","article-title":"An insight to brain targeting utilizing polymeric nanoparticles: effective treatment modalities for neurological disorders and brain tumor","volume":"10","author":"Annu","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.pharmr.2026.100143_bib225","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1159131","article-title":"Dendrimer: an update on recent developments and future opportunities for the brain tumors diagnosis and treatment","volume":"14","author":"Kaurav","year":"2023","journal-title":"Front Pharmacol"},{"issue":"24","key":"10.1016\/j.pharmr.2026.100143_bib226","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413302","article-title":"Nanoparticle strategies for treating CNS disorders: a comprehensive review of drug delivery and theranostic applications","volume":"25","author":"Toader","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100143_bib227","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.3390\/ijms25042360","article-title":"Gold nanoparticles in neurological diseases: a review of neuroprotection","volume":"25","author":"Chiang","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2026.100143_bib228","doi-asserted-by":"crossref","first-page":"72","DOI":"10.37349\/ent.2024.00071","article-title":"Carbon nanotubes as neuroprotective agents","volume":"4","author":"Wilson","year":"2024","journal-title":"Explor Neuroprot Ther"},{"key":"10.1016\/j.pharmr.2026.100143_bib229","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102393","article-title":"Curcumin-loaded polymeric nanomaterials as a novel therapeutic strategy for Alzheimer\u2019s disease: a comprehensive review","volume":"99","author":"Pei","year":"2024","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.pharmr.2026.100143_bib230","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2023.125519","article-title":"Unravelling the in vitro and in vivo potential of selenium nanoparticles in Alzheimer\u2019s disease: a bioanalytical review","volume":"269","author":"Vicente-Zurdo","year":"2024","journal-title":"Talanta"},{"issue":"3","key":"10.1016\/j.pharmr.2026.100143_bib231","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4236\/anp.2012.13007","article-title":"Lipopolysaccharide modified liposomes for amyotropic lateral sclerosis therapy: efficacy in SOD1 mouse model","volume":"1","author":"Wiley","year":"2012","journal-title":"Adv Nanoparticles"},{"key":"10.1016\/j.pharmr.2026.100143_bib232","series-title":"Fundamentals of Pharmaceutical Nanoscience","first-page":"89","article-title":"Lipid nanocapsules: latest advances and applications","author":"Aparicio-Blanco","year":"2024"},{"issue":"suppl 1","key":"10.1016\/j.pharmr.2026.100143_bib233","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood-2019-131806","article-title":"Phase 1, open-label, dose escalation study of I-131-CLR1404 (CLR 131) in patients with relapsed or refractory multiple myeloma","volume":"134","author":"Longcor","year":"2019","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.pharmr.2026.100143_bib240","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1093\/brain\/awz241","article-title":"CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice","volume":"142","author":"Mancuso","year":"2019","journal-title":"Brain"},{"issue":"21","key":"10.1016\/j.pharmr.2026.100143_bib234","doi-asserted-by":"crossref","first-page":"6792","DOI":"10.3390\/jcm12216792","article-title":"Anti-amyloid therapy, AD, and ARIA: untangling the role of CAA","volume":"12","author":"Sin","year":"2023","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.pharmr.2026.100143_bib235","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11060-024-04795-z","article-title":"Focused ultrasound-mediated enhancement of blood-brain barrier permeability for brain tumor treatment: a systematic review of clinical trials","volume":"170","author":"Zhu","year":"2024","journal-title":"J Neurooncol"},{"issue":"4","key":"10.1016\/j.pharmr.2026.100143_bib236","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/s41591-025-03559-0","article-title":"Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer\u2019s disease: a randomized controlled phase 2a trial","volume":"31","author":"Rash","year":"2025","journal-title":"Nat Med"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100143_bib237","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1016\/j.neuron.2024.05.018","article-title":"Microglia protect against age-associated brain pathologies","volume":"112","author":"Munro","year":"2024","journal-title":"Neuron"},{"issue":"16","key":"10.1016\/j.pharmr.2026.100143_bib238","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1016\/j.neuron.2024.05.023","article-title":"Therapeutic potential of human microglia transplantation in a chimeric model of CSF1R-related leukoencephalopathy","volume":"112","author":"Chadarevian","year":"2024","journal-title":"Neuron"},{"issue":"30","key":"10.1016\/j.pharmr.2026.100143_bib239","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb4429","article-title":"Neurotransmitter-derived lipidoids (NT-lipidoids) for enhanced brain delivery through intravenous injection","volume":"6","author":"Ma","year":"2020","journal-title":"Sci Adv"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699726000311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:24:31Z","timestamp":1785147871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699726000311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":239,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0031699726000311"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100143","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Friend or foe? Glial\u2013vascular interactions in health and neurodegenerative disease","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmr.2026.100143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100143"}}